Gail Farfel
Director/Board Member presso DURECT CORPORATION
Patrimonio netto: 117 517 $ in data 31/03/2024
Profilo
Gail M.
Farfel is currently a Director at DURECT Corp., PrintedArt, FAAH Pharma, Inc., Avrobio, Inc., and the American Society For Experimental Neurotherapeutics.
Previously, she held positions as the President, Chief Executive Officer & Director at ProMIS Neurosciences, Inc., Senior Associate Director at Pfizer Inc., Director at Zogenix International Ltd., Chief Clinical & Regulatory Officer at Marinus Pharmaceuticals, Inc., VP-Therapeutic Area & Head-Neuroscience at Novartis Pharmaceuticals Corp., and Global Team Lead at Pfizer Pharmaceuticals, Inc. She also served as the President of G Meredith Consulting LLC.
Dr. Farfel obtained her undergraduate degree from the University of Virginia and her doctorate from The University of Chicago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/08/2023 | 55 192 ( 0.29% ) | 105 417 $ | 31/03/2024 | |
DURECT CORPORATION
0.03% | 26/03/2024 | 10 000 ( 0.03% ) | 12 100 $ | 31/03/2024 |
AVROBIO INC
-.--% | 07/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Gail Farfel
| Società | Posizione | Inizio |
|---|---|---|
| DURECT CORPORATION | Director/Board Member | 25/04/2019 |
| AVROBIO, INC. | Director/Board Member | 21/10/2020 |
PrintedArt
 PrintedArt Other Consumer ServicesConsumer Services PrintedArt provides photography and printing services. | Director/Board Member | - |
| American Society For Experimental Neurotherapeutics | Director/Board Member | - |
FAAH Pharma, Inc.
 FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada. | Director/Board Member | 07/08/2014 |
Precedenti posizioni note di Gail Farfel
| Società | Posizione | Fine |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Chief Executive Officer | 30/12/2023 |
| ZOGENIX, INC. | Corporate Officer/Principal | 01/09/2022 |
| MARINUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
| G Meredith Consulting LLC | President | 01/12/2012 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Gail Farfel
| University of Virginia | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| DURECT CORPORATION | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
PrintedArt
PrintedArt Other Consumer ServicesConsumer Services PrintedArt provides photography and printing services. | Consumer Services |
FAAH Pharma, Inc.
FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada. | Health Technology |
| G Meredith Consulting LLC | |
| American Society For Experimental Neurotherapeutics |
- Borsa valori
- Insiders
- Gail Farfel
